Journal of Clinical Virology
Volume 35, Issue 2 , Pages 185-192 , February 2006

Fibrosis progression in chronic hepatitis C patients with occult hepatitis B co-infection

  • Chee-Kin Hui

      Affiliations

    • Department of Medicine, The University of Hong Kong, Hong Kong SAR, China
    • Centre For The Study of Liver Disease, The University of Hong Kong, Hong Kong SAR, China
    • Corresponding Author InformationCorresponding author. Tel.: +852 28184300; fax: +852 28184030.
    • ,
  • Eva Lau

      Affiliations

    • GI Section, Department of Medicine, Veterans Affairs Medical Center, University of California, San Francisco, San Francisco, USA
    • ,
  • Helen Wu

      Affiliations

    • Roche Diagnostics, San Jose, CA, USA
    • ,
  • Alexander Monto

      Affiliations

    • GI Section, Department of Medicine, Veterans Affairs Medical Center, University of California, San Francisco, San Francisco, USA
    • ,
  • Michael Kim

      Affiliations

    • GI Section, Department of Medicine, Veterans Affairs Medical Center, University of California, San Francisco, San Francisco, USA
    • ,
  • John M Luk

      Affiliations

    • Centre For The Study of Liver Disease, The University of Hong Kong, Hong Kong SAR, China
    • ,
  • George KK Lau

      Affiliations

    • Department of Medicine, The University of Hong Kong, Hong Kong SAR, China
    • Centre For The Study of Liver Disease, The University of Hong Kong, Hong Kong SAR, China
    • ,
  • Teresa Lyn Wright

      Affiliations

    • GI Section, Department of Medicine, Veterans Affairs Medical Center, University of California, San Francisco, San Francisco, USA

Received 18 March 2005 ,Revised 4 July 2005 ,Accepted 10 July 2005.

References 

  1. Bedossa P, Bioulac-Sage P, Callard P, Chevallier M, Degott C, Deugnier Y, et al. The French METAVIR Cooperative Study Group Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology. 1994;20:15–20
  2. Bedossa P, Poynard T. fort he METAVIR Cooperative Study Group An algorithm for the grading of activity in chronic hepatitis C. Hepatology. 1996;24:289–293
  3. Blum HE, Galun E, Liang TJ, von Weizsacker F, Wands JR. Naturally occuriing missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol. 1991;65:1836–1842
  4. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo R. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med. 1999;341:222–226
  5. Carman WF, Van Deursen FJ, Mimms LT, Hardie D, Coppola R, Decker R, et al. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea South Africa and Sardinia. Hepatology. 1997;26:1658–1666
  6. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343–350
  7. Chemin I, Zoulim F, Merle P, Arkhis A, Chevallier M, Kay A, et al. High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. J Hepatol. 2001;34:447–454
  8. Damen M, Sillekens P, Sjerps M, Meisert R, Frantzen I, Reesink HW, et al. Stability of hepatitis C virus RNA during specimen handling and storage prior to NASBA amplification. J Virol Methods. 1998;72:175–184
  9. De Maria N, Colantoni A, Friedlander L, Leandro G, Idilman R, Harig J, et al. The impact of previous HBV infection in patients with chronic hepatitis C. Am J Gastroenterol. 2000;95:3529–3536
  10. Fabris P, Brown D, Tositti G, Bozzola L, Giordani MT, Bevilacqua P, et al. Occult hepatitis B infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C. J Clin Virol. 2004;29:160–166
  11. Fattovich G, Tagger A, Brollo L, Giustina G, Pontisso P, Realdi G, et al. Hepatitis C virus infection in chronic hepatitis B virus carriers. J Infect Dis. 1991;163:400–402
  12. Fukuda R, Ishimura N, Niigaki M, Hamamoto S, Satoh S, Tanaka S, et al. Serologically silent hepatitis B virus co-infection in patients with hepatitis C virus-associated chronic liver disease; clinical and virological significance. J Med Virol. 1999;58:201–207
  13. Georgiadou SP, Zachou K, Rigopoulou E, Liaskos C, Mina P, Gerovasilis F, et al. Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseases. J Viral Hepatol. 2004;11:358–365
  14. Grumayer ER, Panzer S, Ferenci P, Gardner H. Recurrence of hepatitis B in children with serologic evidence of past hepatitis B virus infection undergoing antileukemic chemotherapy. J Hepatol. 1989;8:232–235
  15. Kao JH, Chen PJ, Lai MY, Chen DS. Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C. J Clin Microbiol. 2002;40:4068–4071
  16. Krajden M, Comanor L, Rifkin O, Grigoriew A, Minor JM, Kapke GF. Assessment of hepatitis B virus DNA stability in serum by the Chiron Quantiplex branched-DANN assay. J Clin Microbiol. 1998;36:382–386
  17. Krajden M, Minor JM, Rifkin O, Comanor L. Effect of multiple freeze-thaw cycles on hepatitis B virus DNA and hepatitis C virus RNA quantification as measured with branched-DNA technology. J Clin Microbiol. 1999;37:1683–1686
  18. Kwok S, Higushi R. Avoiding false positives with PCR. Nature. 1989;339:237–238
  19. Liang TJ, Blum HE, Wands JR. Characterization and biological properties of a hepatitis B virus isolated from a patient without hepatitis B serologic markers. Hepatology. 1990;12:204–212
  20. Lo YD, Mehal WZ, Fleming KA. False-positive results and the polymerase chain reaction. Lancet. 1988;ii:679
  21. Lok AS, Liang RHS , Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Gastroenterology. 1991;100:182–188
  22. Michalak TI, Pasquinelli C, Guilhot S, Chisari FV. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest. 1994;93:230–239
  23. Monto A, Alonzo J, Watson JJ, Grunfeld , Wright TL. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus and alcohol. Hepatology. 2002;36:729–736
  24. Nirei K, Kaneko M, Moriyama M, Arakawa Y. The clinical features of chronic hepatitis C are not affected by coexistence of hepatitis B virus DNA in patients negative for hepatitis B surface antigen. Intervirology. 2000;43:95–101
  25. Penna A, Artini M, Cavali A, Levrero M, Bertoletti A, Pilli M, et al. Long lasting T-cell responses following self-limited acute hepatitis B. J Clin Invest. 1996;98:1185–1194
  26. Pollicino T, Squadrito G, Cerenzia G, Cacciola I, Raffa G, Raffa G, et al. Hepatitis B virus maintains its proto-oncogenic properties in the case of occult HBV infection. Gastroenterology. 2004;126:347–350
  27. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR CLINIVIR and DOSVIRC groups. Lancet. 1997;349:825–832
  28. Poynard T, Mathurin P, Lai CL, Gudayer D, Poupon R, Tainturier MH, et al. A comparison of fibrosis progression in chronic liver diseases. J Hepatol. 2003;38:257–265
  29. Sagnelli E, Coppola N, Scolastico C, Mogavero AR, Filippini P, Piccinino F. HCV genotype and “silent” HBV co-infection: two main risk factors for a more severe liver disease. J Med Virol. 2001;64:350–355
  30. Shindo M, Okuno T, Arai K, Matsumoto M, Takeda M, Kashima K, et al. Detection of hepatitis B virus DNA in paraffin-embedded liver tissues in chronic hepatitis B or non-A, non-B hepatitis using polymerase chain reaction. Hepatology. 1991;13:167–171
  31. Stransky J, Malina L, Cieslarova B, Striesky J, Putova I, Horak J. Overt and hidden co-infection with hepatitis B and C viruses in chronic liver disease and porphyria cutanea tarda. Acta Virol. 2000;44:23–28
  32. Thiers V, Nakajima E, Kremsdorf D, Mack D, Schellekens H, Driss F, et al. Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet. 1988;2:1273–1276
  33. Torbenson M, Kannangai R, Astemborski J, Strathdee SA, Vlahov D, Thomas DL. High prevalence of occult hepatitis B in Baltimore injection drug users. Hepatology. 2004;39:51–57
  34. Villa E, Grottola A, Buttafoco P, Trande P, Merighi A, Fratti N, et al. Evidence for hepatitis B virus infection in patients with chronic hepatitis C with and without serological markers of hepatitis B. Dig Dis Sci. 1995;40:8–13
  35. Waite J, Gilson RJC, Weller IVD, Lacey CJ, Hambling MH, Hawkins A, et al. Hepatitis B virus reactivation or reinfection associated with HIV-1 infection. AIDS. 1988;2:443–448
  36. Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, Yotsumoto S, et al. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol. 1994;68:2671–2676
  37. Zhang YY, Hansson BG, Kuo LS, Widell A, Nordenfelt E. Hepatitis B virus DNA in serum and liver is commonly found in Chinese patient with chronic liver disease despite the presence of antibodies to HBsAg. Hepatology. 1993;17:538–544

PII: S1386-6532(05)00196-4

doi: 10.1016/j.jcv.2005.07.003

Journal of Clinical Virology
Volume 35, Issue 2 , Pages 185-192 , February 2006

Article Tools

* Image Usage & Resolution